An estimated 475,000 lives were saved in England and Scotland, but the inquiry says a lower vaccine uptake among some groups ...

Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. While the media's attention has focused on unproven links between ...

Personalized cancer vaccines are showing real clinical results, with melanoma patients on the mRNA-4157/pembrolizumab ...

RAPTER aims to identify the most effective vaccine strategy to help protect the population from pandemics, such as the COVID-19 pandemic. Shown here, a PNNL researcher performs a test to detect the ...

Vaccine development is traditionally driven by financial return opportunities for investors, disease outbreaks, and a specific focus on emerging diseases. However, a new systematic, transparent, and ...

Senior Manufacturing Science Associate Diane Morgan performs an analysis of plasmid DNA at Vernal Biosciences in Colchester on Tuesday, Aug. 12. Photo by Glenn Russell/VTDigger U.S. Health and Human ...

Verndari is one of four companies selected by BARDA to develop alternative vaccine delivery technologies for existing and emerging infectious diseases. Verndari’s VaxiPatch™ technology shows ...

Invivyd, Inc. has submitted a Citizen Petition to the FDA advocating for a new approach to the development of COVID-19 vaccines and monoclonal antibodies (mAbs) to restore public trust in health ...

Osaka, Japan – Norovirus is the leading cause of gastroenteritis and is responsible for hundreds of thousands of deaths every year. However, research progress into antiviral treatments and vaccines ...

The mRNA vaccine CDMO market is rapidly expanding, driven by growing biotech startups, limited in-house manufacturing, and ...